The dysregulation of the expression of pro- and anti-inflammatory mediators, such as tumor necrosis factor-α (TNF-α) and interleukins, may significantly promote leukemia cell growth and survival in AML [9,10]. The gene discussed is TNF; the disease is acute myeloid leukemia.